MedPath

A randomised controlled trial of a telephone-based weight management program for patients with knee osteoarthritis who are overweight or obese.

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Overweight and obesity
Musculoskeletal - Osteoarthritis
Diet and Nutrition - Obesity
Registration Number
ACTRN12615000490572
Lead Sponsor
Hunter New England Population Health, Hunter New England Local Health District.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

Primary complaint of pain in the knee due to knee osteoarthritis.
Aged 18 years or over.
Classified as overweight or obese with a self-reported body mass index (BMI) between 27 or greater and less than 40.
Have access to and can use a telephone.
Duration of longer than 3 months since the onset of knee pain.
Average back pain intensity of 3 or greater out of 10 over the past week on a numerical rating scale of 0 to 10.
Moderate level of interference in activities of daily living (adaption of item 8 on SF-36).

Exclusion Criteria

A known or suspected serious pathology as the underlying cause of knee pain, such as a fracture, infection, rheumatoid arthritis or malignancy (cancer).
A previous history of obesity surgery.
Currently participating in any prescribed, medically supervised or commercial weight loss program.
Knee surgery in the last 6 months or planned surgery in the next 6 months.
Inability to walk unaided.
Unable to comply with the study protocol, adapt meals or exercise, due to non-independent living arrangements.
Any medical or physical impairment, apart from knee pain, precluding safe participation in exercise such as uncontrolled hypertension, or morbid obesity (BMI >40).
Cannot speak and read English.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity measured as the average knee pain over the past week using a numerical rating scale of 0 to 10, where 0 is 'no pain' and 10 is 'the worst possible pain'.[Baseline and at 2, 6, 10, 14, 18, 22 and 26 weeks after randomisation.]
Secondary Outcome Measures
NameTimeMethod
Disability and function assessed using the Western Ontario and McMaster Universities Osteoarthritis Index.[Baseline and at 6 and 26 weeks after randomisation.];Patient quality of life assessed using the SF-12.v2.[Baseline and at 6 and 26 weeks after randomisation.];Diet assessed using a short food frequency questionnaire.[Baseline and at 6 and 26 weeks after randomisation.];Physical activity assessed using the Active Australia Survey.[Baseline and at 6 and 26 weeks after randomisation.];Weight (kg) assessed by a trained research assistant using a portable digital scale measured to the nearest 0.1kg.[26 weeks post-randomisation]
© Copyright 2025. All Rights Reserved by MedPath